SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)

NCT00409539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder Syndrome (OABS)

Interventions

DRUG: Placebo
DRUG: Placebo
DRUG: SMP-986

Sponsor

Sumitomo Pharma America, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]